Message
Message Participating Company
Immunorock Co., Ltd.
Challenge Message
We will bring about a paradigm shift in vaccines by developing an innovative oral vaccine platform.
Appeal Point
Founded in 2021, Immunoloc is a drug discovery venture from Kobe University that develops oral cancer vaccines using an innovative oral vaccine platform based on gut bacteria.
Inclusive ideas – No one left behind
Medical care、welfare